Company / FCF Margin
Vanda Pharmaceuticals Inc. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
6.5%
FY2025
5-year range
6.5% / 23.7%
FY2021-FY2025
Trend
-47.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has fluctuated over the past 10 years, ranging from -164.1% in FY2016 to 23.7% in FY2023.
Based on SEC 10-K filings.
6.5% in FY2025 with a 5-year CAGR of -8.9%.
Declined from 23.7% to 6.5% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -13.7pp
- 5-Year Change
- -8.9pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin decreased 47.6% year-over-year.
- Peak fcf margin was recorded in FY2023.
- Lowest fcf margin in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 6.5% | -47.6% |
| FY2024 | 12.3% | -48.0% |
| FY2023 | 23.7% | +17.6% |
| FY2022 | 20.1% | +1.8% |
| FY2021 | 19.8% | +28.9% |
| FY2020 | 15.3% | +794.1% |
| FY2019 | -2.2% | +66.1% |
| FY2018 | -6.5% | -172.1% |
| FY2017 | 9.0% | +105.5% |
| FY2016 | -164.1% | -39.8% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026